VaramirStart free · no cardSign in
EXEL as of Oct 31 · 08:45 ET
EXELNasdaqBiological Products, (No Diagnostic Substances)

Exelixis, Inc. · Brief

Next report

101 days

Feb 9 · after closeest.Q4 FY26
Earnings

Expected move

Inputs

Implied vs realized

2 reportsHistory
—≥ implied
Q2 FY26±7.4%▼−7.94%×1.07
Oct 29 '26±8.6%▲+4.82%×0.56
quarterimplied−10%0+10%realized×
Oct '26±8.6%▲+4.82%×0.56
Q2 FY26±7.4%▼−7.94%×1.07
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Feb 9 report · est.

—

Linked exposure

EXEL report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±8.6% into Oct 29 earnings (Oct 29 close).Source
Oct 21impliedImplied move: ±7.6% into Nov 3 earnings (Oct 21 close).Source
Oct 19impliedImplied move: ±8.8% into Nov 2 earnings (Oct 19 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.